Publication | Open Access
CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia
45
Citations
42
References
2021
Year
Dual InhibitorUrological ResearchPharmacologyPotent Uricosuric CandidateRenal PathophysiologyMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1